FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vicki Seyfert-Margolis

Research Profile

Living Beings

Ambrosia

Chemicals & Drugs

Disorders

Procedures

Anatomy

Concepts & Ideas

Co-author Network

Publications

TOP 3
Khadir Raddassi; Vicki Seyfert-Margolis; Junbao Yang; Kasia Bourcier; Elizabeth M Bradshaw; Sally C Kent; William W Kwok; Gerald T Nepom; David A Hafler
Increased frequencies of myelin oligodendrocyte glycoprotein/MHC class II-binding CD4 cells in patients with multiple sclerosis.
John H Stone; Peter A Merkel; Robert Spiera; Philip Seo; Carol A Langford; Gary S Hoffman; Cees G M Kallenberg; E William St Clair; Anthony Turkiewicz; Nadia K Tchao; Lisa Webber; Linna Ding; Lourdes P Sejismundo; Kathleen Mieras; David Weitzenkamp; David Ikle; Vicki Seyfert-Margolis; Mark Mueller; Paul Brunetta; Nancy B Allen; Fernando C Fervenza; Duvuru Geetha; Karina A Keogh; Eugene Y Kissin; Paul A Monach; Tobias Peikert; Coen Stegeman; Steven R Ytterberg; Ulrich Specks
Rituximab versus cyclophosphamide for ANCA-associated vasculitis.
Vicki Seyfert-Margolis; Sandy Feng
Tolerance: is it achievable in pediatric solid organ transplantation?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vicki Seyfert-Margolis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Khadir Raddassi; Vicki Seyfert-Margolis; Junbao Yang; Kasia Bourcier; Elizabeth M Bradshaw; Sally C Kent; William W Kwok; Gerald T Nepom; David A Hafler
Increased frequencies of myelin oligodendrocyte glycoprotein/MHC class II-binding CD4 cells in patients with multiple sclerosis.
Journal of immunology (Baltimore, Md. : 1950) 2011;187(2):1039-46.
2010: John H Stone; Peter A Merkel; Robert Spiera; Philip Seo; Carol A Langford; Gary S Hoffman; Cees G M Kallenberg; E William St Clair; Anthony Turkiewicz; Nadia K Tchao; Lisa Webber; Linna Ding; Lourdes P Sejismundo; Kathleen Mieras; David Weitzenkamp; David Ikle; Vicki Seyfert-Margolis; Mark Mueller; Paul Brunetta; Nancy B Allen; Fernando C Fervenza; Duvuru Geetha; Karina A Keogh; Eugene Y Kissin; Paul A Monach; Tobias Peikert; Coen Stegeman; Steven R Ytterberg; Ulrich Specks
Rituximab versus cyclophosphamide for ANCA-associated vasculitis.
The New England journal of medicine 2010;363(3):221-32.
2010: Vicki Seyfert-Margolis; Sandy Feng
Tolerance: is it achievable in pediatric solid organ transplantation?
Pediatric clinics of North America 2010;57(2):523-38, table of contents.
2009: Kevan C Herold; Stephen Gitelman; Carla Greenbaum; Jennifer Puck; William Hagopian; Peter Gottlieb; Peter Sayre; Peter Bianchine; Emelita Wong; Vicki Seyfert-Margolis; Kasia Bourcier; Jeffrey A Bluestone
Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 years.
Clinical immunology (Orlando, Fla.) 2009;132(2):166-73.
2009: Jean Grant; Katarzyna Bourcier; Stephen Wallace; Dalin Pan; Alexis Conway; Vicki Seyfert-Margolis; Paul K Wallace
Validated protocol for FoxP3 reveals increased expression in type 1 diabetes patients.
Cytometry. Part B, Clinical cytometry 2009;76(2):69-78.
2009: Wilco de Jager; Katarzyna Bourcier; Ger T Rijkers; Berent J Prakken; Vicki Seyfert-Margolis
Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays.
BMC immunology 2009;10():52.
2008: Adam L Asare; Svetlana A Kolchinsky; Zhong Gao; Richard Wang; Khadir Raddassi; Katarzyna Bourcier; Vicki Seyfert-Margolis
Differential gene expression profiles are dependent upon method of peripheral blood collection and RNA isolation.
BMC genomics 2008;9():474.
2007: Nalini Kumar Vudattu; Isabelle Magalhaes; Marcus Schmidt; Vicki Seyfert-Margolis; Markus J Maeurer
Reduced numbers of IL-7 receptor (CD127) expressing immune cells and IL-7-signaling defects in peripheral blood from patients with breast cancer.
International journal of cancer. Journal international du cancer 2007;121(7):1512-9.
2007: Sven Klunker; Lavina R Saggar; Vicki Seyfert-Margolis; Adam L Asare; Thomas B Casale; Stephen R Durham; James Francis
Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding.
The Journal of allergy and clinical immunology 2007;120(3):688-95.
2006: Vicki Seyfert-Margolis; Trang D Gisler; Adam L Asare; Richard S Wang; H Michael Dosch; Barbara Brooks-Worrell; George S Eisenbarth; Jerry P Palmer; Carla J Greenbaum; Stephen E Gitelman; Gerald Nepom; Jeffrey A Bluestone; Kevan C Herold
Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study.
Diabetes 2006;55(9):2588-94.
2006: Thomas B Casale; William W Busse; Joel N Kline; Zuhair K Ballas; Mark H Moss; Robert G Townley; Masoud Mokhtarani; Vicki Seyfert-Margolis; Adam L Asare; Kirk Bateman; Yamo Deniz
Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis.
The Journal of allergy and clinical immunology 2006;117(1):134-40.